STANDEX INTERNATIONAL CORP/DE/(SXI)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #424 of 2,860 stocksTOP 25%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
SXI Stock Analysis & AI Quality Score
AI stock analysis and institutional research for STANDEX INTERNATIONAL CORP/DE/ (SXI), a Industrials sector company. 13F Pro's AI-powered ranking engine scores SXI at 68.2/100 on a 32-signal composite quality model, placing it at rank #424 of 2,860 stocks — the top 25% of the AI-ranked universe. SXI scores in the top quartile across profitability (79.7), balance sheet strength (77.8), institutional flow (76.9). Based on the latest XBRL financial filings (Q3 2026), STANDEX INTERNATIONAL CORP/DE/ reports quarterly revenue of $224.6M, net income of $67.0M, free cash flow of $6.2M. Top institutional holders of SXI by reported 13-F value include BlackRock,, WASATCH ADVISORS, Neuberger Berman Group, based on the most recent SEC filings. SXI trades on the NYSE exchange and files with the SEC under CIK 310354. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SXI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for STANDEX INTERNATIONAL CORP/DE/ directly from SEC EDGAR.
What's Driving SXI's Business? Latest 10-Q Breakdown
AI-extracted from STANDEX INTERNATIONAL CORP/DE/'s 10-Q filed 2026-05-06 — Q3 FY2026 (nine months ended March 31, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.
Nine-month revenue of $663.3M (+16.8% YoY) driven by $66.9M from acquisitions and $56.8M gain on Federal Industries divestiture, with operating income surging 165% to $156.0M.
Biggest Revenue Drivers
Total revenue: $663.3M+16.8% YoY
Acquisitions contributed $44.5M; organic growth +5.4% from fast-growth markets and new products
Organic sales +3.2% from improved demand in Europe, North America and Asia
McStarlite acquisition added $17.5M; organic growth +12.2% from space and aviation markets
Custom Biogenic Systems acquisition added $4.8M, offset by organic decline from NIH funding cuts
Largest Expense Items
Gross margin improved to 41.4% from 39.4% due to pricing disciplines and productivity actions
Increased by acquisition expenses, R&D, and higher U.S. medical costs
Facility rationalizations and announced closure of four sites in Engraving & Hydraulics
Margins: Gross margin expanded 200 basis points to 41.4% from 39.4% year-over-year, driven by pricing disciplines and productivity initiatives across segments. Operating margin benefited significantly from the $56.8M gain on Federal Industries divestiture and acquisition contributions, though underlying operational performance showed disciplined margin management amid integration activities.
Watch Items from the Filing
- Redeemable noncontrolling interest in Narayan (9.9%) remeasured at $44.2M as of March 31, 2026, with $18.8M adjustment in nine-month period based on contractual redemption value; potential future redemption obligations.
- Scientific segment organic decline of $2.3M driven by NIH funding cuts affecting academic and research institutions; margin compressed from 24.5% to 22.6% nine-month YoY.
- Debt of $472.8M at March 31, 2026 (down from $552.5M June 30, 2025); leverage ratio 2.18:1 and interest coverage 4.54:1, both within covenants but elevated debt from acquisitions.
- Tariff exposure acknowledged as impacting multiple segments; company evaluating impact of Supreme Court decision on certain IEEPA tariffs with uncertain refund timing and amounts.
AI-extracted and verified against SEC EDGAR filing text. Not investment advice.
Revenue
Q3 2026
$224.6M
Net Income
Q3 2026
$67.0M
Free Cash Flow
Q3 2026
$6.2M
ROIC
Q3 2026
7.4%
D/E Ratio
Q3 2026
0.63
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
+9.6% YoYNet Income
-23.7% YoYOperating Income
-8.0% YoYEPS (Diluted)
-24.4% YoYTotal Assets
+55.9% YoYTotal Debt
+271.1% YoYOp. Cash Flow
-24.9% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Revenue | $790.1M +9.6% | $720.6M -2.8% | $741.0M +12.9% | $656.2M +8.6% | $604.5M -5.5% | $639.9M |
| Net Income | $55.8M -23.7% | $73.1M -47.4% | $139.0M +281.1% | $36.5M +80.7% | $20.2M -70.3% | $67.9M |
| Operating Income | $93.5M -8.0% | $101.7M -40.5% | $171.1M +189.2% | $59.2M -2.3% | $60.5M -23.8% | $79.5M |
| EPS (Diluted) | $4.64 -24.4% | $6.14 -47.0% | $11.58 +289.9% | $2.97 +82.2% | $1.63 -69.7% | $5.38 |
| Total Assets | $1.57B +55.9% | $1.01B -1.9% | $1.02B +6.5% | $962.2M +3.4% | $930.9M +1.0% | $921.9M |
| Total Debt | $552.5M +271.1% | $148.9M -14.2% | $173.4M -13.1% | $199.5M +0.2% | $199.2M +0.8% | $197.6M |
| Operating Cash Flow | $69.6M -24.9% | $92.7M +2.0% | $90.8M +8.6% | $83.6M +76.9% | $47.2M -35.6% | $73.3M |
AI Insight: SXI Ratio Trends
Q1 2026 margins and returns spike dramatically—operating margin to 40.4%, ROIC to 29.6%—but quarter-to-quarter volatility and depressed Q4 2025 profitability raise sustainability concerns.
• Operating margin surged to 40.4% in Q1 2026 from 16.1% in Q4 2025; net profit margin jumped to 29.8% from 1.0%.
• ROIC expanded to 29.6% in Q1 2026 from 11.5% in Q4 2025; ROE and ROA also spiked to 35.5% and 17.5% respectively.
• Leverage declined to 0.63 D/E in Q1 2026, down from 0.76–0.84 range in prior three quarters.
⚠ Q4 2025 showed severe profitability collapse—net margin fell to 1.0%, ROE to 1.2%—raising questions about Q1 2026 normalization.
⚠ Significant quarter-to-quarter volatility in profitability metrics (Q4 collapse, Q1 spike) suggests potential one-offs or seasonality masking underlying trends.
Track SXI with AI-powered research
10 AI analysts debate this stock daily. Free to start.
Available Research
13F Pro tracks comprehensive data for STANDEX INTERNATIONAL CORP/DE/ including:
Top Institutional Holders of SXI
BlackRock, Inc.
$441.0M1,730,550 shWASATCH ADVISORS LP
$335.7M1,317,226 shNeuberger Berman Group LLC
$202.7M795,300 shVANGUARD PORTFOLIO MANAGEMENT LLC
$189.2M742,492 shVANGUARD CAPITAL MANAGEMENT LLC
$138.5M543,626 shSTATE STREET CORP
$127.0M498,361 shBARROW HANLEY MEWHINNEY & STRAUSS LLC
$120.8M474,027 shDIMENSIONAL FUND ADVISORS LP
$81.3M318,909 shSILVERCREST ASSET MANAGEMENT GROUP LLC
$80.1M314,404 shGEODE CAPITAL MANAGEMENT, LLC
$76.2M298,863 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $441.0M | 1,730,550 |
| WASATCH ADVISORS LP | $335.7M | 1,317,226 |
| Neuberger Berman Group LLC | $202.7M | 795,300 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $189.2M | 742,492 |
| VANGUARD CAPITAL MANAGEMENT LLC | $138.5M | 543,626 |
| STATE STREET CORP | $127.0M | 498,361 |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | $120.8M | 474,027 |
| DIMENSIONAL FUND ADVISORS LP | $81.3M | 318,909 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $80.1M | 314,404 |
| GEODE CAPITAL MANAGEMENT, LLC | $76.2M | 298,863 |
More Industrials Companies
View all Industrials →Unlock Full Research for SXI
Get detailed financial analysis, insider activity, institutional flows, AI-powered debates, and quality rankings for STANDEX INTERNATIONAL CORP/DE/ and 2,800+ other companies.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is SXI a good stock to buy?
13F Pro's AI-powered analysis of STANDEX INTERNATIONAL CORP/DE/ (SXI) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Industrials sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for SXI are available on the SXI stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own SXI?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling SXI. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of STANDEX INTERNATIONAL CORP/DE/'s investment landscape.